Morgan Stanley Maintains Equal-Weight on Johnson & Johnson, Lowers Price Target to $169
Portfolio Pulse from Benzinga Newsdesk
Morgan Stanley analyst Terence Flynn has maintained an Equal-Weight rating on Johnson & Johnson (NYSE:JNJ) but has reduced the price target from $170 to $169.
January 24, 2024 | 8:01 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Morgan Stanley has maintained an Equal-Weight rating on Johnson & Johnson and lowered the price target by $1 to $169.
The adjustment in price target is minimal, suggesting a neutral outlook without significant short-term impact. The Equal-Weight rating indicates that Morgan Stanley's view on JNJ's stock performance is in line with the market expectations.
CONFIDENCE 90
IMPORTANCE 60
RELEVANCE 100